1,5-anhydroglucitol has been researched along with Impaired Glucose Tolerance in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Y; He, X; Ma, X; Shen, Y; Su, H; Wang, Y; Ying, L; Zhou, J; Zhu, W | 1 |
| Chen, C; Chen, J; Guo, H; Sun, Z; Tan, Y; Wang, B; Wang, X; Wang, Y; Yang, J; Yuan, Y | 1 |
| Katsuno, T; Konishi, K; Koyama, H; Kusunoki, Y; Matsuo, T; Matsutani, S; Namba, M; Ohigashi, M; Osugi, K; Tsunoda, T; Washio, K | 1 |
| Hata, J; Hirakawa, Y; Kishimoto, H; Kitazono, T; Kiyohara, Y; Koga, M; Mukai, N; Nakamura, U; Ninomiya, T; Ohara, T; Yoshida, D | 1 |
| Fukuhara, M; Hata, J; Hirakawa, Y; Hotta, T; Ikeda, F; Kang, D; Kitazono, T; Kiyohara, Y; Koga, M; Mukai, N; Nakamura, U; Ninomiya, T | 1 |
| Amaya, N; Arakawa, K; Fukuoka, Y; Ikeda, H; Ishida, K; Kaseno, K; Lee, JD; Morishita, T; Sato, T; Shiomi, Y; Tada, H; Tama, N; Uzui, H | 1 |
| Kasayama, S; Koga, M; Mukai, M; Murai, J; Saito, H | 1 |
| Ito, C | 1 |
| Fukumura, Y; Kobayashi, I; Tsukui, S | 1 |
| Shiba, T | 1 |
| Akaoka, I; Funato, H; Inoue, T; Kawasaki, T; Koshibu, E; Miyashita, H; Ogata, N; Yamanouchi, T; Yoshimura, T | 1 |
| Kondo, T; Miyakawa, M; Shimada, N; Shirasaya, K; Takahashi, E; Yoshida, K | 1 |
| Arumanayagam, M; Lau, TK; Rogers, MS; Tam, WH | 1 |
| Ichiyanagi, K; Inoue, T; Kashiwabara, A; Kawasaki, T; Ogata, E; Ogata, N; Sekino, N; Yamanouchi, T; Yoshimura, T | 1 |
2 review(s) available for 1,5-anhydroglucitol and Impaired Glucose Tolerance
| Article | Year |
|---|---|
[Diagnosis and tests for impaired glucose tolerance and borderline type].
Topics: Biomarkers; Blood Glucose; Deoxyglucose; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosuria; Humans; Insulin; Serum Albumin | 2005 |
[Screening of glucose intolerance with fasting blood samples].
Topics: Biomarkers; Blood Glucose; Blood Specimen Collection; Clinical Trials as Topic; Deoxyglucose; Diabetes Mellitus; Fasting; Glucose Intolerance; Glycated Hemoglobin; Mass Screening; Risk | 1996 |
12 other study(ies) available for 1,5-anhydroglucitol and Impaired Glucose Tolerance
| Article | Year |
|---|---|
1,5-Anhydroglucitol × glycated hemoglobin A
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Young Adult | 2020 |
Reference intervals for serum 1,5-anhydroglucitol of a population with normal glucose tolerance in Jiangsu Province.
Topics: Adult; Aged; Biomarkers; Blood Glucose; China; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Middle Aged; Reference Values; Uric Acid; Young Adult | 2020 |
Association of time in range with hemoglobin A1c, glycated albumin and 1,5-anhydro-d-glucitol.
Topics: Adult; Aged; Blood Glucose Self-Monitoring; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucose Intolerance; Glucose Metabolism Disorders; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycemic Control; Humans; Male; Middle Aged; Retrospective Studies; Serum Albumin; Time Factors | 2021 |
Alternative Measures of Hyperglycemia and Risk of Alzheimer's Disease in the Community: The Hisayama Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Deoxyglucose; Female; Follow-Up Studies; Glucose Intolerance; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Incidence; Independent Living; Japan; Male; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Risk Factors; Serum Albumin | 2017 |
Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study.
Topics: Adult; Aged; Atherosclerosis; Biomarkers; Blood Glucose; Blood Pressure; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cohort Studies; Cross-Sectional Studies; Deoxyglucose; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Independent Living; Insulin Resistance; Japan; Male; Middle Aged; Prospective Studies; Serum Albumin; Statistics as Topic | 2015 |
Effect of postprandial hyperglycaemia on coronary flow reserve in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Coronary Circulation; Coronary Vessels; Deoxyglucose; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Intolerance; Humans; Hyperglycemia; Male; Middle Aged | 2015 |
Habitual intake of dairy products influences serum 1,5-anhydroglucitol levels independently of plasma glucose.
Topics: Biomarkers; Blood Glucose; Dairy Products; Deoxyglucose; Diet; Feeding Behavior; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Serum Albumin; Surveys and Questionnaires | 2010 |
Decreased serum 1,5-anhydroglucitol in nondiabetic subjects with a family history of NIDDM.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Glycosuria; Humans; Isomerism; Middle Aged; Nuclear Family; Reference Values | 1996 |
Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.
Topics: Acetylglucosaminidase; Adult; Albuminuria; Biomarkers; Blood Glucose; Blood Pressure; Blood Proteins; Cholesterol; Cholesterol, HDL; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Follow-Up Studies; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Isomerism; Male; Middle Aged; Prospective Studies; Regression Analysis; Sulfonylurea Compounds; Time Factors; Triglycerides | 1998 |
Economic evaluation of alternative indicators for screening for diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Deoxyglucose; Diabetes Mellitus, Type 2; Fructosamine; Glucose Intolerance; Glycated Hemoglobin; Humans; Male; Mass Screening; Middle Aged; Models, Econometric; Sensitivity and Specificity | 1999 |
The predictive value of serum 1,5-anhydro-D-glucitol in pregnancies at increased risk of gestational diabetes mellitus and gestational impaired glucose tolerance.
Topics: Adolescent; Adult; Antimetabolites; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes, Gestational; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Middle Aged; Predictive Value of Tests; Pregnancy; Sensitivity and Specificity | 2001 |
Post-load glucose measurements in oral glucose tolerance tests correlate well with 1,5-anhydroglucitol, an indicator of overall glycaemic state, in subjects with impaired glucose tolerance.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Cross-Sectional Studies; Deoxyglucose; Female; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Longitudinal Studies; Male; Middle Aged | 2001 |